ArticleMedicine2018

Successful treatment of high-risk myelodysplastic syndrome with decitabine-based chemotherapy followed by haploidentical lymphocyte infusion: A case report and literature review.

Yuanyuan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.